You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
25 September 2020
Germany’s Neuraxpharm will soon have a new private-equity owner. Permira has agreed to acquire the pharmaceutical company specialising in central nervous system (CNS) products from Apax Partners for an undisclosed sum.
24 September 2020
Alliance Pharma has divided its product portfolio into Consumer Healthcare brands and Prescription Medicines. The company said the Consumer Healthcare business generated sales of GBP43.8 million (USD55.8 million) in the first half of 2020, representing 67% of its total sales.
24 September 2020
Alliance Pharma remains keen to build its consumer healthcare presence through acquisitions, according to chief executive officer Peter Butterfield.
23 September 2020
Two Canadian industry associations – Consumer Health Products Canada and Food & Consumer Products of Canada – have merged to create a single body called Food, Health & Consumer Products of Canada (FHCP).
23 September 2020
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has introduced stronger warnings for prescribed and OTC medicines containing opioids, while New Zealand’s Medsafe is to reconsider a recent recommendation for pholcodine and has reached a settlement over Arthrem.
21 September 2020
Europe’s Committee for Medicinal Products for Human Use (CHMP) has confirmed its recommendation that all medicines containing ranitidine should be suspended in the European Union.
21 September 2020
Dr Reddy’s has launched store-brand equivalents of Alcon’s Pataday eye allergy products in the US, Nature’s Sunshine has a new business model and New Zealand’s industry association has a fresh image.
15 September 2020
Nestlé is keen to make more acquisitions, including “sizeable” deals, according to chief financial officer François-Xavier Roger.
14 September 2020
Stada has hired Accord Healthcare’s Paulina Romaniszyn as country head and general manager of its Polish business.
11 September 2020
Australia has once again rejected an application to switch the erectile-dysfunction drug sildenafil from prescription to non-prescription status but is set to make another triptan available without a prescription.